Concepedia

Diandra Zipinotti dos Santos

DZ

6

Publications

201

Citations

6

H-Index

2017

Active since

Affiliations

Universidade Federal do Espírito Santo(Current)

Instituto Nacional do Câncer

The University of Sydney

UNSW Sydney

Diandra Zipinotti dos Santos is an author at Universidade Federal do Espírito Santo specializing in oncology, pharmacology, and radiation oncology.

ORCID

Top concepts

Publications per year

2017–2022

6

Publications

6

Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines

Isabella dos Santos Guimarães, Taciane Ladislau-Magescky, Nayara Gusmão Tessarollo et al. · Pharmacological Reports · 2017 · 58 citations

, , +6

Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover

Nikki L. Raftopulos, Tinashe C. Washaya, Andreas Niederprüm et al. · Cancer & Metabolism · 2022 · 48 citations · Full text

Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment

Taciane Barbosa Henriques, Diandra Zipinotti dos Santos, Isabella dos Santos Guimarães et al. · Aging · 2021 · 37 citations · Full text

Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance

Paulo C. Lyra, Thales C. Nepomuceno, Marcele Lorentz Mattos de Souza et al. · Genetics in Medicine · 2020 · 29 citations · Full text

Atorvastatin improves cisplatin sensitivity through modulation of cholesteryl ester homeostasis in breast cancer cells

Diandra Zipinotti dos Santos, Isabella dos Santos Guimarães, Mariam F. Hakeem-Sanni et al. · Discover Oncology · 2022 · 16 citations · Full text

Rows per page

1–5 of 6